Protective immunity against Trypanosoma cruzi

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 288-294

  Parodi, Cecilia ^a   Padilla, Angel Marcelo ^a   Basombrío, Miguel Angel ^a  

^a UNIVERSIDAD NACIONAL DE SALTA   (Argentina)

Author keywords

CD8+ T cells; Immunity; Trypanosoma cruzi

Indexed keywords

ANIMALIA; TRYPANOSOMA CRUZI;

EID: 68949198436     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900038     Document Type: Article

References (43)

1. +T cells in chronic Chagas' disease pa-tients. Int Immunol 18: 465-471.
2. Alvarez MG, Postan M, Weatherly DB, Albareda MC, Sidney J, Sette A, Olivera C, Armenti AH, Tarleton RL, Laucella SA 2008. HLA Class I-T cell epitopes from transsialidase proteins reveal functionally distinct subsets of CD8 T cells in chronic Chagas disease. PLoS Negl Trop Dis 2: e288.
3. +T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 8: 379-385.
4. Appay V, Rowland-Jones SL 2004. Lessons from the study of T-cell differentiation in persistent human virus infection. Semin Immunol 16: 205-212.
5. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439: 682-687.
6. Barrio AB, Van Voorhis W, Basombrío MA 2007. Trypanosoma cruzi: attenuation of virulence and protective immunogenicity after monoallelic disruption of the cub gene. Exp Parasitol 117: 382-389.
7. Basombrío MA 1981. Resistencia a reinfecciones por el Trypanosoma cruzi en ratones chagásicos. Medicina (Bs. As.) 41: 230-232.
8. Basombrío MA 1990. Trypanosoma cruzi: partial prevention of the natural infection of guinea pigs with a killed parasite vaccine. Exp Parasitol 71: 1-8.
9. Basombrío MA, Arredes H 1987. Long-term immunological response induced by attenuated Trypanosoma cruzi in mice. J Parasitol 73: 236-238.
10. Basombrío MA, Arredes H, Rossi R, Molina de Raspi E 1986. Histopathological and parasitological evidence of immunization of mice against challenge with 17 wild isolates of Trypanosoma cruzi. Int J Parasitol 16: 375-380.
11. Basombrío MA, Arredes H, Uncos R, Alvarez E 1987. Field trial of vaccination against American trypanosomiasis (Chagas' disease) in domestic guinea pigs. Am J Trop Med Hyg 37: 57-62.
12. Basombrío MA, Besuschio S 1982. Trypanosoma cruzi culture used as vaccine to prevent chronic Chagas' disease in mice. Infect Immun 36: 351-356.
13. Basombrío MA, Besuschio S, Cossio P 1982. Side effects of immunization with live attenuated Trypanosoma cruzi in mice and rabbits. Infect Immun 36: 342-350.
14. Basombrío MA, Gómez L, Padilla AM, Ciaccio M, Nozaki T, Cross GAM 2002a. Targeted deletion of the gp 72 gene decreases the infectivity of Trypanosoma cruzi for mice and insect vectors. J Parasitol 88: 489-493.
15. Basombrío MA, Gorla D, Catalá S, Segura MA, Mora MC, Gomez L, Nasser J 1996. Number of vector bites determining the infection of guinea pigs with Trypanosoma cruzi. Mem Inst Oswaldo Cruz 91: 421-423.
16. Basombrío MA, Nasser J, Segura MA, Gomez L 1997. Trypanosoma cruzi: effect of immunization on the risk if vector-delivered infection in guinea pigs. J Parasitol 83: 1059-1062.
17. Basombrío MA, Segura MA, Mora MC, Gómez L 1993. Field trial of vaccination against american trypanosomiasis (Chagas' disease) in dogs. Am J Trop Med Hyg 49: 143-151.
18. Basombrío MA, Segura MA, Nasser J 2002b. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase-chain reaction in mice. J Parasitol 88: 1107-1112.
19. Basso B, Castro I, Introini V, Truyens C, Moretti E 2007. Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi. Vaccine 25: 3855-3858.
20. Bustamante JM, Bixby LM, Tarleton RL 2008. Drug-induced cure drives conversion to a stable and protective CD8+T central memory response in chronic Chagas' disease. Nat Med 14: 542-550.
21. Cardozo R 2003. Estudio del cuadro histopatológico provocado por aislados de diversos linajes de Trypanosoma cruzi provenientes de la Provincia del Chaco, Thesis, Universidad Nacional de Salta, Argentina, p. 33-34.
22. Cuneo C, Molina de Raspi E, Basombrío MA 1989. Prevention of electrocardiographic and histopathologic alterations in the murine model of Chagas disease by preinoculation of an attenu-ated Trypanosoma cruzi strain. Rev Inst Med Trop São Paulo 31: 248-255.
23. Garg N, Tarleton RL 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi. Infect Immun 70: 5547-5555.
24. Gomez LE, Nasser JR, Basombrío MA 1996. Complete immunization against Trypanosoma cruzi verified in individual mice by complement-mediated lysis. Mem Inst Oswaldo Cruz 91: 56-61.
25. +T cells for effective immunotherapy. Curr Opin Immunol 18: 363-370.
26. +CTL and B cell-mediated cross-priming. J Immunol 179: 6889-6900.
27. Karp CL, Arwaerter PG 2007. Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens. Clin Infect Dis 45: 1208-1213.
28. Krettli A, Brener Z 1982. Protective effects of specific antibodies in Trypanosoma cruzi infections. J Immunol 128: 2008-2012.
29. Laucella SA, Postan M, Martin D, Hubby Fralish B, Albareda MC, Alvarez MG, Lococo B, Barbieri G, Viotti RJ, Tarleton RL 2004. Frequency of interferon-gamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189: 909-918.
30. Machado AV, Cardoso JE, Claser C, Rodrigues MM, Gazzinelli R,Bruna-Romero O 2006 Long-term protective immunity induced against Trypanosoma cruzi infection after vaccination with re-combinant adenoviruses encoding amastigote surface protein-2 and transsialidase. Human Gene Therapy 17: 898-908.
31. Martin DL, Tarleton RL 2005. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J Immunol 174: 1594-1601.
32. +T-cell responses to Trypanosoma cruzi are highly focused on strain-variant transsialidase epitopes. PLoS Pathog 2: e77.
33. Menezes H 1969. Active immunization of dogs with a non virulent strain of Trypanosoma cruzi. Rev Inst Med Trop São Paulo 11: 258-263.
34. Muñoz-Fernandez MA, Fernandez MA, Fresno M 1992. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism. Immunol Lett 33: 35-40.
35. Simao Ferreira M 1999. Chagas disease and immunosuppression. Mem Inst Oswaldo Cruz 94: 325-327.
36. Tarleton RL 2001. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31: 550-554.
37. Tarleton RL 2003. Chagas disease: a role for autoimmunity? Trends Parasitol 19: 447-451.
38. Tarleton RL, Grusby MJ, Postan M, Glimcher HL 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int Immunol 8: 13-22.
39. Tarleton RL, Koller BH, Latour A, Postan M 1992. Susceptibility of [beta] 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-340.
40. +cy-totoxic T cells after infection with Trypanosoma cruzi in nai{dotless}ve or vaccinated mice. Infect Immun 74: 2477-2481.
41. Vasconcelos JR, Hiyane MI, Marinho CR, Claser C, Machado AM, Gazzinelli RT, Bruña-Romero O, Alvarez JM, Boscardin SB, Rodrigues MM 2004. Protective immunity against Trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and transsialidase. Hum Gene Ther 15: 878-886.
42. Vogt J, Alba Soto CD, Mincz MP, Mirkin GA 2008. Impaired Trypanosoma cruzi-specific IFN-gamma secretion by T cells bearing the BV9 T-cell receptor is associated with local IL-10 production in non-lymphoid tissues of chronically infected mice. Microbes Infect 10: 781-790.
43. Zago MP, Barrio AB, Cardozo RM, Duffy T, Schijman AG, Basom-brío MA 2008. Impairment of infectivity and immunoprotective effect of a LYT1 null mutant of Trypanosoma cruzi. Inf Immun 76: 443-451.